Filing Details

Accession Number:
0001209191-20-027373
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-05 21:13:09
Reporting Period:
2020-05-01
Accepted Time:
2020-05-05 21:13:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1731348 Tilray Inc. TLRY Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746080 Michael Auerbach 1100 Maughan Road
Nanaimo A1 V9X IJ2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class 2 Common Stock Acquisiton 2020-05-01 107,290 $0.19 588,306 No 4 M Direct
Class 2 Common Stock Acquisiton 2020-05-01 18,290 $0.19 606,596 No 4 M Direct
Class 2 Common Stock Disposition 2020-05-01 95,131 $7.38 511,465 No 4 S Direct
Class 2 Common Stock Disposition 2020-05-01 125,580 $7.38 385,885 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class 2 Common Stock Stock Option (Right to Buy) Disposition 2020-05-01 107,290 $0.00 107,290 $0.19
Class 2 Common Stock Stock Option (Right to Buy) Disposition 2020-05-01 18,290 $0.00 18,290 $0.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-06-17 No 4 M Direct
3,168 2025-09-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class 2 Common Stock 7,891 Indirect By: M3 Daat, LLC
Class 2 Common Stock 667,025 Indirect By: Murphy Ofutt Common LLC
Class 2 Common Stock 1,705,342 Indirect By: Murphy Ofutt LLC
Footnotes
  1. The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. The shares were a part of the pro rata release of 11 million shares of Class 2 common stock held by the former equity holders of Privateer Holdings, Inc. ("Privateer"). The shares were released from lock-up on April 3, 2020 under the Agreement and Plan of Merger and Reorganization, dated September 9, 2019, by and among Tilray, Privateer, Down River Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Tilray.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0450 to $7.3817, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4.
  5. The shares represent shares issued upon exercise of options, which options were a part of the pro rata release of 11 million shares of Class 2 common stock held by the former equity holders of Privateer Holdings, Inc. ("Privateer"), which were released from lock-up on April 3, 2020 under the Agreement and Plan of Merger and Reorganization, dated September 9, 2019, by and among Tilray, Privateer, Down River Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Tilray.
  6. The Reporting Person is a member of M3 Daat, LLC and has sole voting and investment power with respect to the shares held by M3 Daat, LLC.
  7. Mr. Auerbach serves as General Partner of Murphy Ofutt Common, LLC, a multi-member limited liability company. Mr. Auerbach has sole voting and investment power with respect to the shares held by Murphy Ofutt Common, LLC
  8. The shares subject to this option are fully vested.